NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Novelos Therapeutics Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Novelos Therapeutics Announces $9 Million Private Placement
2009 SEP 7 ... Pulmonology, Purdue Pharma LP, Respiratory Infection, Therapies, Therapy, Treatment, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Novelos Therapeutics, Inc.
Price: $3.00
*
Novelos Therapeutics and MUSC Present Two Posters at AACR 2007 Annual Meeting
2007 APR 30 ... Keywords: Cancer, Cancer Research, Clinical Trial Research, Oncology, Therapy, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Cancer
Price: $3.00
*
Novelos Therapeutics Announces $15 Million Private Placement
2007 APR 30 ... Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development ...
Subject: Novelos Therapeutics, Inc.
Price: $3.00
*
Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
2007 JUL 2 ... Gynecology, Oncology, Ovarian Cancer, Ovarian Neoplasms, Pharmaceuticals, Treatment, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Ovarian Cancer
Price: $3.00
*
Novelos Therapeutics Announces Enrollment of 1st Patient in Phase 2 Breast Cancer Trial at MUSC / Hollings Cancer Center
2007 JUN 18 ... Clinical Trial Research, Drug Therapy, Hematology, Oncology, Women's Health, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Breast Cancer
Price: $3.00
*
Novelos Therapeutics Appoints Dr. James Manuso to Board of Directors
2007 AUG 27 ... Biopharmaceuticals, Biotechnology, Business, Financing, Personnel, Therapy, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioengineering
Price: $3.00
*
Novelos Therapeutics CEO Buys 50,000 Shares of NVLT
2007 SEP 3 ... Keywords: Bioengineering, Biopharmaceuticals, Biotechnology, Therapy, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioengineering
Price: $3.00
*
Novelos Therapeutics Closes $15 Million Private Placement
2007 MAY 14 ... Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development ...
Subject: Novelos Therapeutics, Inc.
Price: $3.00
*
Novelos Therapeutics Concludes Nov-205 Hepatitis C Trial Based on Favorable Safety Profile
2007 DEC 24 ... Oncology, Pharmaceuticals, Ribavirin, Therapies, Therapy, Treatment, Virology, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Hepatitis C Virus
Price: $3.00
*
Novelos Therapeutics enrolls first patient in hepatitis C trial with NOV-205
2006 OCT 23 ... Novelos Therapeutics, Inc. (NVLT) announced that the first patient has been enrolled in a ...
Subject: Hepatitis C Research
Price: $3.00
*
Novelos Therapeutics enrolls first patient in pivotal Phase III lung cancer trial
2006 DEC 4 ... Novelos Therapeutics, Inc. (NVLT) announced that the first patient has been enrolled in the ...
Subject: Lung Cancer
Price: $3.00
*
Novelos Therapeutics provides an activity update
2006 NOV 20 ... Novelos Therapeutics provides an activity update. This trend article is an ... developments at Novelos Therapeutics. Report 1: Novelos Therapeutics, Inc. (NVLT) has received a notice of allowance from the U.S. Patent and Trademark Office for ...
Subject: Novelos Therapeutics
Price: $3.00
*
Novelos Therapeutics provides information on its latest news and research developments
2007 JAN 23 ... Novelos Therapeutics provides information on its latest news and research developments. ... developments at Novelos Therapeutics. Report 1: Novelos Therapeutics, Inc. (NVLT) announced that the first patient has been enrolled in the pivotal Phase III ...
Subject: Novelos Therapeutics
Price: $3.00
*
Novelos Therapeutics Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial
2008 MAR 24 ... Paclitaxel, Pharmaceuticals, Pulmonology, Respiratory Infection, Therapies, Treatment, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Lung Cancer
Price: $3.00
*
Novelos Therapeutics receives notice of allowance for fifth U.S. patent related to lung cancer drug
2006 OCT 9 ... Novelos Therapeutics, Inc. (NVLT) has received a notice of allowance from the U.S. Patent and ...
Subject: Cancer Therapy
Price: $3.00
*
Novelos Therapeutics to Present and Webcast at Rodman & Renshaw 9th Annual Healthcare Conference
2007 NOV 12 ... Hepatitis, Infectious Disease, Pharmaceuticals, Therapies, Therapy, Treatment, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Hepatitis
Price: $3.00
*
Novelos Therapeutics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
2008 NOV 17 ... Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development ...
Subject: Novelos Therapeutics, Inc.
Price: $3.00
*
Novelos Therapeutics Updates ''Dirty Bomb'' Treatment Development Program
2007 JUN 4 ... trial." Keywords: Cancer, Clinical Trial Research, Oncology, Therapy, Novelos Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Cancer
Price: $3.00
*
Octillion Appoints Mr. Barry Honig to Newly Formed Advisory Board
2007 NOV 5 ... (NASDAQ: ZVUE), Towerstream Corp. (NASDAQ: TWER), China Clean Energy (CCGY) and Novelos Therapeutics (NVLT). Mr. Honig, whose particular expertise is in ... of capital and achieving listings on the NASDAQ Stock Market, including: Infologix Inc. (NASDAQ: IFLG), Akeena Solar (NASDAQ: AKNS), Neuro Hitech Inc. (NASDAQ: NHPI), Health ...
Subject: Octillion Corp.
Price: $3.00
*
Reports describe the most recent news from Novelos Therapeutics
2006 DEC 6 ... Reports describe the most recent news from Novelos Therapeutics. This trend article is an immediate alert from NewsRx to ... developments at Novelos Therapeutics. Report 1: Novelos Therapeutics, Inc. (NVLT) announced that the first patient has been enrolled in a hepatitis C trial with ...
Subject: Novelos Therapeutics
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login